SCHEMBL2944326

SCHEMBL2944326

CN1C=CC(C2=C3C=CC(Cl)(N3)C(Cl)(C3=CCN(C)C=C3)C3=NC(Cl)(C=C3)C(Cl)(C3=CCN(C)C=C3)c3ccc([nH]3)C(C3=CCN(C)C=C3)=C3C=CC2=N3)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474513 0.88 — —
SCHEMBL7146576 0.83 — —
SCHEMBL4954616 0.83 — —
SCHEMBL5947696 0.78 — —
SCHEMBL4128661 0.78 — —
SCHEMBL7149929 0.77 — —
SCHEMBL8183373 0.75 — —
SCHEMBL8182556 0.74 — —
SCHEMBL7148663 0.74 — —
SCHEMBL8184161 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086312-A1 REDUCED ADAPTIVE MICROBIAL RESISTANCE TREATMENT FOR FLESH EATING DISEASE SALAZAR JENNIE (US) 2021-05-06 — — WO claimed
US-20210121441-A1 REDUCED ADAPTIVE MICROBIAL RESISTANCE TREATMENT FOR FLESH EATING DISEASE (necrotizing fasciitis) ZAMADAR MATIBUR RAHAMAN (US) 2021-04-29 — — US claimed
US-5541633-A Ink jet printing of concealed images on carbonless paper XEROX CORPORATION (US) 1996-07-30 — — US claimed
US-5286286-A Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores XEROX CORPORATION (US) 1994-02-15 — — US claimed
US-5256193-A Porphyrin chromophore and dendrimer ink composition XEROX CORPORATION (US) 1993-10-26 — — US claimed
US-11850233-B2 Reduced adaptive microbial resistance treatment for flesh eating disease (necrotizing fasciitis) ZAMADAR MATIBUR RAHAMAN (US) 2023-12-26 — — US disclosed
EP-3140306-B1 PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC FRONTIER SCIENT INC (US) 2021-11-17 — — EP disclosed
WO-2021086312-A1 REDUCED ADAPTIVE MICROBIAL RESISTANCE TREATMENT FOR FLESH EATING DISEASE SALAZAR JENNIE (US) 2021-05-06 — — WO disclosed
US-20210121441-A1 REDUCED ADAPTIVE MICROBIAL RESISTANCE TREATMENT FOR FLESH EATING DISEASE (necrotizing fasciitis) ZAMADAR MATIBUR RAHAMAN (US) 2021-04-29 — — US disclosed
US-20210026054-A1 PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC FRONTIER SCIENTIFIC INC. 2021-01-28 — — US disclosed
US-20180259693-A1 PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC FRONTIER SCIENTIFIC, INC. (US) 2018-09-13 — — US disclosed
US-20170235034-A1 PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC FRONTIER SCIENTIFIC, INC. (US) 2017-08-17 — — US disclosed
US-20040023397-A1 Tamper-resistant authentication mark for use in product or product packaging authentication VERIFICATION TECHNOLOGIES, INC. 2004-02-05 — — US disclosed
US-20040000787-A1 Authentication mark for a product or product package SUN CHEMICAL B.V. (AN) 2004-01-01 — — US disclosed
US-20030112423-A1 On-line verification of an authentication mark applied to products or product packaging VERIFICATION TECHNOLOGIES, INC. 2003-06-19 — — US disclosed
US-20030047610-A1 Product packaging including digital data SPENCER TRASK 2003-03-13 — — US disclosed
US-5709737-A AQUEOUS LIQUID VEHICLE, COLORANT, ALCOHOL ADDITIVE; SUITABLE FOR MICROWAVE DRYING PROCESSES XEROX CORPORATION (US) 1998-01-20 — — US disclosed
US-5541633-A Ink jet printing of concealed images on carbonless paper XEROX CORPORATION (US) 1996-07-30 — — US disclosed
US-5286286-A Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores XEROX CORPORATION (US) 1994-02-15 — — US disclosed
US-5256193-A Porphyrin chromophore and dendrimer ink composition XEROX CORPORATION (US) 1993-10-26 — — US disclosed
Send feedback